Pay in 4 interest-free payments of $7.07 Learn more
Ships within 48 hours · Estimated delivery Aug 15 - Aug 20
Initially supported by seed funding from Lupin, the US-based entity will seek to raise funds in a renewed attempt at taking oncology assets to global clinical trials Trinomab becomes the first biotech to wrap up an IPO on the Shanghai STAR Market this year, raking in new funds to support its pipeline of novel anti-infective antibodies
The variable no invoice line captures Every dollar you spend on a GLP-1 program buys a compound that acts on biology you already carry
How these medications work When we eat, our gut releases hormones that regulate hunger and blood sugar
Only 37% of consumers are familiar with GLP-1 medications, compared with 47% globally, suggesting the market is still at an early stage of adoption, the report noted
Yet, her optimism was short-lived
US$ 23.88
US$ 24.35
US$ 24.59
US$ 25.13
US$ 28.57
